Description
The OTC women’s health market encompasses a wide variety of products that have been determined safe and effective as over-the-counter products. The market is driven by several factors including increasing number of baby boomers entering old age, increasing incidences of diseases; product demand; and several others.
In response to many inquiries from readers of Kalorama Information’s March 2003 publication Women’s Health: Worldwide Prescription Drug Markets, 3rd Edition, we embarked on a supplemental study that goes beyond the prescription market to cover over-the-counter products in the United States.
The report covers the following segments:
- Adult incontinence
- Infection
- Menstrual pain relievers
- Family planning
- Feminine hygiene, and
- Osteoporosis
Amongst these segments, new product development and additional regulatory review and approval of new OTC drug classifications in areas including infection, family planning and osteoporosis are likely to have the greatest impact on this market.
The report includes statistical information for conditions and diseases affecting the U.S. population, including detail discussions, tables and figures. Each segment provides an overview, current OTC products on the market, market estimates and forecasts, and competitive analysis of leading players. In addition to abovementioned information, the report includes current trends and opportunities affecting the industry and present and future market drivers.
The information for this report was gathered using secondary research including comprehensive research of secondary sources such as company literature, databases, investment reports, and medical and business journals.
All market data pertain to the U.S. market. The base year for data was 2002. Historical data are provided for 1998 through 2002, with forecast data provided for 2003 through 2006. Compound annual growth rates (CAGRs) are provided for the 1998-2002, 2003-2006, and 1998-2006 periods for each industry segment covered.
Table of Contents
Chapter One: Executive Summary
- Overview
- Scope and Methodology
- Size and Growth of the Market
- Trends and Opportunities
- Leading Competitors
Chapter Two: The Products
- Overview
- Rx-to-OTC Evolution
- Focus on Women’s OTC
Chapter Three: Incontinence
- Overview
- Incidence and Prevalence
- Current OTC Products
- Market Size and Growth
- Competitive Market
Chapter Four: Feminine Infection
- Overview
- Urinary Tract Infection
- Yeast Infection
- Incidence and Prevalence
- Current OTC Products
- Market Size and Growth
- Competitive Market
Chapter Five: Menstrual Pain Relievers
- Overview
- Abnormal Uterine Bleeding
- Amenorrhea
- Dysmenorrhea
- Premenstrual Syndrome and Premenstrual Dysphoric Disorder (PMDD)
- Incidence and Prevalence
- Current OTC Products
- Market Size and Growth
- Competitive Market
Chapter Six: Family Planning
- Overview
- Contraception
- Ovulation Prediction Kits
- Pregnancy Tests Kits
- Incidence and Prevalence
- Current OTC Products
- Market Size and Growth
- Competitive Market
Chapter Seven: Feminine Hygiene
- Overview
- Douche
- Feminine Deodorant
- Lubricants
- Current OTC Products
- Market Size and Growth
- Competitive Market
Chapter Eight: Osteoporosis
- Overview
- Incidence and Prevalence
- Current OTC Products
- Market Size and Growth
- Competitive Market
Chapter Nine: Total Market Summary
- Overview
- Total Market Size and Forecast
- Market by Segments
- Competitive Analysis
- Market Analysis
Chapter Ten: Trends and Opportunities
- Overview
- The Family Planning Products
- Condoms – More for Women
- Emergency Contraceptives (EC)
- Today Sponge Hits Back
- Personal Lubricants
- Third Class of Drugs – OTC Behind The Counter
- Pharmacist Role
- New Marketing Channels
- Women’s Health – Retail Chain’s Focus
- Direct to OTC Marketing
- Online Healthcare Market
- Changing OTC Strategies
- New OTC Labeling
Chapter Eleven: Market Drivers
- Overview
- Rx-to-OTC Switches – Dual Regulatory Status
- Targeting The Female Gender
- Rx-to-OTC Switch and Patent Expiration
Chapter Twelve: The Consumer
- Overview
- The Simmons Survey System
- Consumer Focus (Women’s Ailments)
- Consumer Focus (Vitamins and Minerals)
- Consumer Focus (Menstrual Pain Relievers)
Chapter Thirteen: Future Drivers
- Towards Self Medication
- FDA Regulation for OTC Products
- ePharmacies: Online Drug Stores
Chapter Fourteen: Company Profiles
- Bayer Consumer Care Division
- Carter-Wallace Inc.
- Columbia Laboratories, Inc.
- Durex Consumer Products, Inc.
- Glaxo SmithKline Consumer Healthcare
- Inverness Medical Innovations Inc.
- Johnson & Johnson
- Kimberly Clark Corporation – Adult Incontinence Products
- McNeil Consumer Healthcare
- Personal Products Company
- Pfizer Inc.
- Playtex Products Inc.
- Procter & Gamble
- Purdue Frederick Company
- Quality Health Products, Inc.
- Schering-Plough Corporation
- Unipath Diagnostic Company
- Upsher-Smith Laboratories, Inc.
- Whitehall Robins Healthcare (Wyeth Consumer Healthcare)
Appendix: Company Directory
Selected List of Exhibits
Chapter One: Executive Summary
- Table 1-1 The U.S. Market for OTC Women’s Health Products 1998-2006 (Revenues and Growth Rate)
Chapter Three: Incontinence
- Table 3-1 Estimated Female Prevalence of Incontinence (World and United States)
- Table 3-2 The U.S. Market for OTC Adult Incontinence Products for Women 1998-2002: (Market Size and Growth Rate)
- Table 3-3 Percent Distribution of U.S. Population by Age Bracket, 1996-2010 from Age Under 5 to Age 65 and Over
- Table 3-4 Women Population Projections (Numbers in ‘000): (Population, All ages and from Age Under 17 to Age 85 and Over)
- Table 3-5 The U.S. Market for OTC Adult Incontinence Products for Women 2003-2006: (Market Size)
- Table 3-6 The U.S. Market for Adult Incontinence Drugs for Women Market Share by Leading Supplier 2002 (Marketers and Market Shares)
Chapter Four: Feminine Infection
- Table 4-1 Incidence of Urinary Tract Infection (World and United States)
- Table 4-2 United States Yearly Incidence of Yeast Infections, 2002: (U.S. Yearly Incidence and Percent of Population Affected)
- Table 4-3 The U.S. Market for OTC Infection Products for Women 1998-2002 (Market Size and Growth)
- Table 4-4 The U.S. Market for OTC Infection Products for Women 2003-2006: (Market Size)
- Table 4-5 The U.S. Market for Feminine Infection Market Share by Leading Supplier 2002
Chapter Five: Menstrual Pain Relievers
- Table 5-1 Incidence of Menstrual Pain in United States: (Menstrual Disorders/Dysmenorrhea)
- Table 5-2 Prescription Drugs with Anticipated OTC Approval by Ingredient, Trade Name, Distributor and Current Activity
- Table 5-3 The U.S. Market for OTC Menstrual Pain Relievers 1998-2002: (Total Market Size and Growth Rate)
- Table 5-4 The U.S. Market for OTC Menstrual Pain Relievers 2003-2006
- Table 5-5 The U.S. Market for Menstrual Relievers Market Share by Leading Supplier 2002
Chapter Six: Family Planning
- Table 6-1 Incidence / Prevalence of Contraception Use (World and United States)
- Table 6-2 Estimated World and U.S. Contraceptive Use by Method: (Female Sterilization, Oral Pill, Implant, Injectable, Intrauterine Device, Diaphragm, Female Condom and Other Methods)
- Table 6-3 List of Major Manufacturers and Respective Brands in Ovulation Prediction Kits Segment
- Table 6-4 List of Major Manufacturers and Respective Brands in Ovulation Prediction Kits Segment
- Table 6-5 The U.S. Market for OTC Family Planning Products for Women 1998-2002: (Market Size and Growth Rate)
- Table 6-6 The U.S. Market for OTC Family Planning Products for Women 2003-2006: (Market Size)
- Table 6-7 The U.S. Market for Family Planning Products for Women Market Share by Leading Supplier 2002: (Three Marketers)
- Table 6-8 The U.S. Market for Pregnancy Test Kits Market Share by Leading Supplier 2002: (Three Marketers)
- Table 6-9 The U.S. Market for Ovulation Prediction Test Kits Market Share by Leading Supplier 2002: (Three Marketers)
- Table 6-10 The U.S. Market for Female Contraceptives Market Share by Leading Supplier 2002: (Three Marketers)
Chapter Seven: Feminine Hygiene
- Table 7-1 The U.S. Market for OTC Feminine Hygiene Products 1998-2002: (Market Size and Growth Rate)
- Table 7-2 The U.S. Market for OTC Feminine Hygiene 2003-2006
- Table 7-3 The U.S. Market for Feminine Hygiene Market Share by Leading Supplier 2002
Chapter Eight: Osteoporosis
- Table 8-1 Estimated Female Prevalence of Osteoporosis (World and United States)
- Table 8-2 The U.S. Market for OTC Osteoporosis Treatment Products for Women 1998-2002: (Market Size and Growth)
- Table 8-3 The U.S. Market for OTC Osteoporosis Treatment Products for Women 2003-2006: (Market Size)
- Table 8-4 The U.S. Market for OTC Osteoporosis Treatment for Women Market Share by Leading Supplier 2002
Chapter Nine: Total Market Summary
- Table 9-1 The U.S. Market for OTC Women’s Health Products 1998-2006: (Market Size and Growth Rate): Compounded Annual Growth Rate: (1998-2002, 2002-2006, and 1998-2006)
- Table 9-2 The U.S. OTC Women’s Health Market – Segment’s Share 2002-2006: (Adult Incontinence, Family Planning, Menstrual Pain, Infection, Feminine hygiene, and Osteoporosis)
- Table 9-3 The U.S. OTC Women’s Health Market by Segment 1998-2006 (in millions): (Adult Incontinence, Family Planning, Menstrual Pain, Infection, Feminine hygiene, and Osteoporosis)
- Table 9-4 The U.S. OTC Women’s Health Market Revenue Distribution by Segment 1998-2006
Chapter Ten: Trends and Opportunities
- Table 10-1 Selected New Product Introductions in 2002-2003 (28 Companies and 36 Brands)
Chapter Twelve: The Consumer
- Table 12-1 Demographic Factors Favoring the Incidence of Infection Among U.S. Women (Age, Race, Education, Household Income, and Marital Status)
- Table 12-2 Demographic Factors Favoring the Incidence of Osteoporosis Among U.S. Women: (Age, Race, Education, Household Income, and Marital Status)
- Table 12-3 Demographic Factors Favoring the Incidence of Urinary Tract Infection Among U.S. Women (Age, Race, Education, Household Income, and Marital Status)
- Table 12-4 Demographic Factors Favoring the Most Often Use of One-A-Day brand of Vitamin/Mineral Supplements (One-A-Day Essential vs. One-A-Day Maximum) by U.S. Women (Age, Race, Education, Household Income, and Marital Status)
- Table 12-5 Demographic Factors Favoring the Most Often Use of Oscal by U.S. Women (Age, Race, Education, Household Income, and Marital Status)
- Table 12-6 Demographic Factors Favoring the Most Often Use of Midol Menstrual Pain Reliever by U.S. Women (Age, Race, Education, Household Income, and Marital Status)
- Table 12-7 Demographic Factors Favoring the Most Often Use of Motrin by U.S. Women (Age, Race, Education, Household Income, and Marital Status)
- Table 12-8 Demographic Factors Favoring the Most Often Use of Tylenol by U.S. Women (Age, Race, Education, Household Income, and Marital Status)
Chapter Thirteen: Future Drivers
Table 13-1 Selected Marketers and Brands, 2002: (67 Marketers, 136 Brands and Description)
